Blueprint Medicines
company
Funding Round
Post-IPO Equity
Money Raised
$ 325.50M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Nov 12, 2014 | Series C | $ 50M | Casdin Capital,Cowen Group,etc. | Detail |
| Apr 11, 2011 | Series A | $ 40M | F-Prime Capital,Third Rock Ventures | Detail |
| Dec 6, 2016 | Post-IPO Equity | $ 134.50M | Detail | |
| Mar 29, 2017 | Post-IPO Equity | $ 215.60M | Detail | |
| Jan 7, 2014 | Series B | $ 25M | Biotechnology Value Fund,Casdin Capital,etc. | Detail |
| Jan 1, 2012 | Series Unknown | 0 | Eight Roads Ventures | Detail |
| Apr 27, 2015 | IPO | $ 147M | Detail |
